Quantcast

Latest RegeneRx Stories

2008-11-04 09:00:30

REGENERX BIOPHARMACEUTICALS, INC. (AMEX:RGN) announced today that J.J. Finkelstein, RegeneRx's president and chief executive officer, will present a company update at the Rodman & Renshaw Annual Global Investment Conference in New York at 10:20 a.m. ET on Tuesday, November 11.

2008-10-22 12:00:51

REGENERX BIOPHARMACEUTICALS, INC. (AMEX:RGN) announced today that J.J. Finkelstein, RegeneRx's president and chief executive officer, will present a company update at the 7th Annual BIO Investor Forum in San Francisco, CA, on Thursday, October 30, 2008 at 2:00 p.m. ET.

2008-07-04 12:00:28

Regenerx Biopharmaceuticals has completed enrollment and dosing of 40 healthy subjects for its Phase Ia clinical trial testing RGN-352, an injectable formulation of Tâ4 for potential use in treating acute myocardial infarction patients.


Word of the Day
begunk
  • To befool; deceive; balk; jilt.
  • An illusion; a trick; a cheat.
The word 'begunk' may come from a nasalised variant of Scots begeck ("to deceive, disappoint"), equivalent to be- +‎ geck.